2019
DOI: 10.1016/j.bbadis.2019.03.012
|View full text |Cite
|
Sign up to set email alerts
|

LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(16 citation statements)
references
References 43 publications
0
15
0
Order By: Relevance
“…It is feasible that LRP1 directly suppresses adult OPC proliferation. LRP1 is known to modulate the proliferation of other cell types (Boucher et al, 2007;Basford et al, 2009;Mao et al, 2016;Safina et al, 2016;Yang et al, 2018;Zucker et al, 2019), suppressing the hypoxia-induced proliferation of mouse and human retinal endothelial cells by regulating the activity of poly (ADP-ribose) polymerase-1 (PARP-1; Mao et al, 2016), and suppressing the proliferation of cultured mouse vascular smooth muscle cells by reducing PDGFRβ activity (Boucher et al, 2003;Basford et al, 2009). However, the inability of Lrp1 deletion to acutely influence OPC proliferation in vivo or directly influence OPC proliferation in vitro (Figure 7; Lin et al, 2017), may suggest that LRP1 affects OPC proliferation indirectly.…”
Section: Why Does Lrp1 Deletion Have a Delayed Effect On Opc Prolifermentioning
confidence: 99%
“…It is feasible that LRP1 directly suppresses adult OPC proliferation. LRP1 is known to modulate the proliferation of other cell types (Boucher et al, 2007;Basford et al, 2009;Mao et al, 2016;Safina et al, 2016;Yang et al, 2018;Zucker et al, 2019), suppressing the hypoxia-induced proliferation of mouse and human retinal endothelial cells by regulating the activity of poly (ADP-ribose) polymerase-1 (PARP-1; Mao et al, 2016), and suppressing the proliferation of cultured mouse vascular smooth muscle cells by reducing PDGFRβ activity (Boucher et al, 2003;Basford et al, 2009). However, the inability of Lrp1 deletion to acutely influence OPC proliferation in vivo or directly influence OPC proliferation in vitro (Figure 7; Lin et al, 2017), may suggest that LRP1 affects OPC proliferation indirectly.…”
Section: Why Does Lrp1 Deletion Have a Delayed Effect On Opc Prolifermentioning
confidence: 99%
“…Additionally, we found some interactions uniquely from adipose endothelial cells (Figure 5B, in the red boxes) that might affect tumor growth. First, adipose endothelial cells expressed LAGLS9 and PDGFB binding to LRP1, which can enhance expression of collagen 1, 49 thus consolidating the connection between tumor cells and adipose endothelial cells. Second, adipose endothelial cells expressed EFNA1 binding with EPHA7 and EPHA4, both of which were reported to accelerate tumor growth 50‐52 .…”
Section: Resultsmentioning
confidence: 99%
“…and PDGFB binding to LRP1, which can enhance expression of collagen 1, 49 thus consolidating the connection between tumor cells and adipose endothelial cells. Second, adipose endothelial cells expressed EFNA1 binding with EPHA7 and EPHA4, both of which were reported to accelerate tumor growth.…”
Section: Heterogeneity Of Nk Cells In Gistmentioning
confidence: 99%
“…In IPAH lung, based on the MSX1 protein localization in remodeled pulmonary arteries, we believe that MSX1 could potentially be localized in the dedifferentiated PASMCs. This is because, according to the current concept of PH pathogenesis, PASMCs can undergo a phenotypic switch from a contractile (differentiated) to a synthetic/proliferative (dedifferentiated) state that drives medial thickening and vascular remodeling in PH [ 47 , 48 ]. It is therefore possible that, in PAH, ectopic MSX1 expression could prompt dedifferentiation of PASMCs and influence remodeling of pulmonary arteries.…”
Section: Discussionmentioning
confidence: 99%